FLUCONAZOLE-RESISTANT CANDIDA-ALBICANS AFTER LONG-TERM SUPPRESSIVE THERAPY

被引:87
|
作者
SANGUINETI, A
CARMICHAEL, JK
CAMPBELL, K
机构
[1] UNIV ARIZONA,COLL MED,DEPT INTERNAL MED,TUCSON,AZ 85719
[2] TUCSON HOSP,DEPT INTERNAL MED,MED EDUC PROGRAM,TUCSON,AZ
[3] UNIV ARIZONA,COLL MED,DEPT FAMILY MED,INFECT DIS SECT,TUCSON,AZ 85719
[4] UNIV ARIZONA,COLL PHARM,TUCSON,AZ 85719
关键词
D O I
10.1001/archinte.153.9.1122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Candida albicans is generally considered to be susceptible, in vivo, to fluconazole. In the population infected with human immunodeficiency virus, recurrent bouts of oral and esophageal candidiasis have led to increasing use of fluconazole for long-term prophylaxis. With prolonged therapy, the issue of developing resistance emerges. We report a case of fluconazole-resistant C albicans esophagitis that developed after fluconazole was used for more than 600 days.
引用
收藏
页码:1122 / 1124
页数:3
相关论文
共 50 条
  • [41] TREATMENT OF CANDIDA-ALBICANS FUNGEMIA WITH FLUCONAZOLE
    GRANINGER, W
    PRESTERIL, E
    SCHNEEWEISS, B
    TELEKY, B
    GEORGOPOULOS, A
    JOURNAL OF INFECTION, 1993, 26 (02) : 133 - 146
  • [42] FAILURE OF FLUCONAZOLE THERAPY FOR STERNAL OSTEOMYELITIS DUE TO CANDIDA-ALBICANS
    DAN, M
    PRIEL, I
    CLINICAL INFECTIOUS DISEASES, 1994, 18 (01) : 126 - 127
  • [43] Candida norvegensis: A fluconazole-resistant species
    Sandven, P
    Nilsen, K
    Digranes, A
    Tjade, T
    Lassen, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) : 1375 - 1376
  • [44] Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis
    Cernicka, Jana
    Subik, Julius
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 27 (05) : 403 - 408
  • [45] ESOPHAGITIS BY CANDIDA-ALBICANS RESISTANT TO FLUCONAZOLE - INVITRO THERAPEUTIC FAILURE AND CORRELATION
    DRONDA, F
    RODRIGUEZTUDELA, JL
    MERA, P
    MARTINEZSUAREZ, J
    MEDICINA CLINICA, 1992, 99 (05): : 199 - 199
  • [46] EFFECTIVENESS OF FLUCONAZOLE IN MURINE CANDIDA-ALBICANS AND BACTERIAL CANDIDA-ALBICANS PERITONITIS AND ABSCESS FORMATION
    SAWYER, RG
    ADAMS, RB
    ROSENLOF, LK
    MAY, AK
    PRUETT, TL
    JOURNAL OF MEDICAL AND VETERINARY MYCOLOGY, 1995, 33 (02): : 131 - 136
  • [47] Design, synthesis, and evaluation of caffeic acid amides as synergists to sensitize fluconazole-resistant Candida albicans to fluconazole
    Dai, Li
    Zang, Chengxu
    Tian, Shujuan
    Liu, Wei
    Tan, Shanlun
    Cai, Zhan
    Ni, Tingjunhong
    An, Maomao
    Li, Ran
    Gao, Yue
    Zhang, Dazhi
    Jiang, Yuanying
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (01) : 34 - 37
  • [48] Comparison of Difference Between Fluconazole and Silver Nanoparticles in Antimicrobial Effect on Fluconazole-Resistant Candida Albicans Strains
    Alimehr, Shadi
    Abad, Hamide Shekari Ebrahim
    Shahverdi, Ahmadreza
    Hashemi, Jamal
    Zomorodian, Kamyar
    Moazeni, Maryam
    Vosoghian, Sahar
    Rezaie, Sassan
    ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES, 2015, 3 (02):
  • [49] Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy
    Shahid, Zainab
    Sobel, Jack D.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2009, 64 (03) : 354 - 356
  • [50] Therapeutic efficacy of voriconazole against a fluconazole-resistant Candida albicans isolate in a vaginal model
    Gonzalez, Gloria M.
    Portillo, Omar J.
    Uscanga, Grecia I.
    Andrade, Samantha E.
    Robledo, Miguel
    Rodriguez, Candelario
    Elizondo, Mariana
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (03) : 571 - 573